These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32524759)

  • 1. Biochemical evaluation of processed ascites in patients undergoing cell-free and concentrated ascites reinfusion therapy.
    Nakamura H; Hanafusa N; Kitamura K; Nakamura H; Sekihara H; Shimizu K; Anayama M; Makino Y; Tamura K; Nagasawa M
    Ther Apher Dial; 2020 Oct; 24(5):516-523. PubMed ID: 32524759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites.
    Ito T; Hanafusa N; Soneda N; Isoai A; Kobayashi R; Torii N; Kato M
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3224-3232. PubMed ID: 34250635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of Major Problems in the Cell-Free and Concentrated Ascites Reinfusion Therapy System─Constructing of Cell-Free and Concentrated Ascites Reinfusion Therapy System Using External Pressure for Filtration.
    Yoshizawa M; Nakatsuji Y
    Ther Apher Dial; 2019 Jun; 23(3):233-236. PubMed ID: 31033153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Free and Concentrated Ascites Reinfusion Therapy for Decompensated Liver Cirrhosis.
    Kozaki K; IInuma M; Takagi T; Fukuda T; Sanpei T; Terunuma Y; Yatabe Y; Akano K
    Ther Apher Dial; 2016 Aug; 20(4):376-82. PubMed ID: 27523078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan.
    Yorioka N; Namisaki T; Shibamoto A; Suzuki J; Kubo T; Iwai S; Tomooka F; Tanaka M; Takeda S; Fujimoto Y; Enomoto M; Muarata K; Inoue T; Tsuji Y; Fujinaga Y; Nishimura N; Kitagawa K; Takaya H; Kaji K; Kawaratani H; Akahane T; Mitoro A; Yamazaki M; Yoshiji H
    In Vivo; 2023; 37(3):1226-1235. PubMed ID: 37103093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of intractable ascites by continuous reinfusion of the sterilized, cell-free and concentrated ascitic fluid.
    Inoue N; Yamazaki Z; Oda T; Sugiura M; Wada T
    Trans Am Soc Artif Intern Organs; 1977; 23():699-702. PubMed ID: 910402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
    Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
    Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single center experience of cell-free and concentrated ascites reinfusion therapy in malignancy related ascites.
    Ito T; Hanafusa N; Fukui M; Yamamoto H; Watanabe Y; Noiri E; Iwase S; Miyagawa K; Fujita T; Nangaku M
    Ther Apher Dial; 2014 Feb; 18(1):87-92. PubMed ID: 24499089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison Between the Internal and External Pressure Filtration Method of Cell-Free and Concentrated Ascites Reinfusion Therapy Using the Same Cancerous Ascites.
    Yamada S; Hasegawa M; Nii N; Kato M; Ohashi A; Suzuki R; Komatsu M; Abe K; Hata Y; Takahashi K; Hayashi H; Koide S; Tsuboi N; Inaguma D; Yuzawa Y
    Ther Apher Dial; 2019 Jun; 23(3):237-241. PubMed ID: 31025830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan.
    Iwasa M; Ishihara T; Kato M; Isoai A; Kobayashi R; Torii N; Soneda N; Takei Y
    Intern Med; 2019 Nov; 58(21):3069-3075. PubMed ID: 31292400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of resistant ascites by continuous ultrafiltration--reinfusion of ascitic fluid.
    Villeneuve JP; Thuot C; Marleau D; Joly JG; Huet PM; Viallet A
    Can Med Assoc J; 1977 Dec; 117(11):1296-8. PubMed ID: 72594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel automatic ascites filtration and concentration equipment with multi-ring-type roller pump units for cell-free and concentrated ascites reinfusion therapy.
    Okahisa T; Sogabe M; Nakagawa T; Tanaka K; Tomonari T; Taniguchi T; Takahashi A; Kinouchi Y; Nishioka J; Igata N; Yanagawa H; Komatsu T; Ohnishi Y; Fukuhara M; Ishikawa M; Shibata H; Shinomiya H; Nakasono M; Kishi F; Komai K; Tatsuki Y; Murashima T; Deguchi Y; Aramaki H; Fukumitsu H; Takayama T
    Artif Organs; 2020 Aug; 44(8):856-872. PubMed ID: 32187379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrated ascitic fluid reinfusion in cirrhotic patients: a simplified method.
    Albalate M; López García MD; Vázquez A; De Sequera P; Marriott E; Tan D; Ortiz A; Casado S; Carreño V; Caramelo C
    Am J Kidney Dis; 1997 Mar; 29(3):392-8. PubMed ID: 9041215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report.
    Yasuda K; Asou M; Asakawa T; Araki M
    J Med Case Rep; 2020 Oct; 14(1):192. PubMed ID: 33050943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascitic IL-10 Concentration Predicts Prognosis of Patients Undergoing Cell-Free and Concentrated Ascites Reinfusion Therapy.
    Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
    Ther Apher Dial; 2020 Feb; 24(1):90-95. PubMed ID: 31157953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reinfusion ascites therapy: considerations after a year's experience].
    Russo GE; Caramiello MS; Vitaliano E; Fagiolo M; Pazienza M; Testorio M; Carmenini G; Sagliaschi G
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):79-83. PubMed ID: 7480964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Method for Stabilizing the Proportion of the Reduced Form of Albumin During Cell-Free and Concentrated Ascites Reinfusion Therapy in Patients with Malignant Ascites.
    Ohashi A; Nakai S; Yamada S; Kato M; Hasegawa M
    Ther Apher Dial; 2019 Jun; 23(3):242-247. PubMed ID: 31033167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
    Zaak D; Paquet KJ; Kuhn R
    Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.
    Khan FY
    Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell-free and concentrated ascites reinfusion therapy(CART)].
    Yoshizawa A; Gyouda Y; Ishiguro T; Matsuzaki K; Yoshizawa T
    Gan To Kagaku Ryoho; 2012 Dec; 39 Suppl 1():33-5. PubMed ID: 23268893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.